Why invest in Avocet?

Avocet Polymer Technologies was founded in 1996 and has brought leading products to market that are based on known pharmacology and known drug delivery technology in the United States. Headquartered in Chicago, the company designs, manufacturers, develops and markets drugs, ointments and devices for the treatment of scar conditions. Avocet has more than 30 patents and has several new scar prevention and reduction products under development.

Avocet Polymer Technologies develops scar treatment products that incorporate scientific innovation that improve upon other options currently available in the market. Avocet has two main products in the market today: Avogel and Avosil. Avogel provides groundbreaking efficacy through its utilization of water, possessing extensive advantages over silicone and other gel sheetings. Scar formation reduction can be manipulated by increasing the water content and temperature of the scar. By using Avogel, both the hydration and temperature of the scar are increased cooperatively, producing optimal results through the minimization of scar formation. Avogel relieves pain, itching, and tenderness of scars while hydrating and softening scar tissue. Avogel can treat various sizes and types of scars, continually the solution recommended by leaders in the surgical, dermatological, and pharmaceutical industry.

Avocet has a robust IP portfolio covering products ranging from those that prevent scar formation to those that cause older scars to shrink.

Because of the effectiveness of our products, our products are available nationwide. Avogel and Avosil are available via dropship via Cardinal and McKesson. Our items can be purchased at CVS, Walgreens, Target, Wal-Mart, and many other large drug chains. Our products can also be purchased online at Amazon.com and MakeMeHeal.com